Consequences of Sanctuary Cities Come Home to Roost
President Trump Understands Information Warfare
About That Judge Who Tried to Strip Trump's Commander-in-Chief Powers Last Night...
A Rampaging Senator Gets a Theatrical Review, and Democrats Have Rediscovered the American...
Is LA Mayor Karen Bass Still Working for Cuban Intelligence?
Spain’s Impossible Dream of ‘Green’ Electricity
Secretary Burgum Is Right to Stamp Out Radicalism in Our National Parks
Parents, Your Children Do Not Belong to the Government
Throwing a Flag at the FCC’s Overzealous Enforcement
Trump Is Right to Pull the Plug on NPR and PBS
Newsom Ignores Kamala Harris' Call During LA Riots
Holdout GOP Senators Flip on Trump’s 'Big, Beautiful Bill' As Deal Nears Deadline
'Wipe Them Out': Fetterman Backs Israel’s Strike on Iran and Calls for More
First They Escaped Border Patrol, Now They Escape ICE Facility: Four Illegal Immigrants...
Tim Walz Stuns Critics by Calling China the World’s 'Moral Authority' Amid Rising...
Tipsheet

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’

AP Photo/Pablo Martinez Monsivais, File

Speaking during remarks to a J.P. Morgan healthcare conference this week, Pfizer CEO Albert Bourla openly stated current vaccines the company developed for Wuhan coronavirus offer "limited, if any" protection against contracting current variants of the disease. He then encouraged booster shots. 

The statement from Bourla comes as the Biden administration continues to justify vaccine mandates for federal workers, contractors and private businesses. The Supreme Court heard arguments about President Biden's mandates for private companies and medical workers last week. A ruling is expected soon on the constitutionality of the mandates. 

A number of people who have pointed out the waning efficacy of Pfizer's vaccines, which Bourla touted last year as being "100 percent" effective against contracting or transmitting the virus, have been banned by social media companies. 

Meanwhile, Bourla also announced this week the company is developing a vaccine specific to Omicron. It is expected to be ready in March when health officials predict the latest wave of the mild variant will already be over. 

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos